Clinical Trials on Thermoregulation Impairment in United States

Total 1525 results

Vanda Pharmaceuticals

Completed

Pharmacokinetics of Tasimelteon in Subjects With Mild or Moderate Hepatic Impairment

Hepatic Impairment

United States
University of Chicago

Completed

Developing a Mobile Method to Measure THC-induced Impairment (AIS)

Measuring THC-induced Cognitive Impairment Using a Mobile Application

United States
VA Office of Research and Development

Completed

Visuomotor Rehabilitation Training for Manual Task Deficits From Macular Scotomas (VRT)

Scotoma, Central | Central Visual Impairment

United States
New York State Psychiatric Institute
Duke University; Queens College, The City University of New York

Active, not recruiting

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment (CogTraining)

Cognitive Impairment | Mild Cognitive Impairment | Cognitive Decline | Memory Disorders | Memory Impairment | Cognitive Disorder

United States
Novartis Pharmaceuticals

Completed

Study to Assess the Pharmacokinetics of Pelacarsen (TQJ230) in Participants With Mild Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment

United States
Corcept Therapeutics

Completed

A Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Relacorilant

Hepatic Impairment

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.

Hepatic Impairment

United States
Bristol-Myers Squibb

Completed

A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment

Hepatic Impairment

United States
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

Study of Danicopan in Participants With Hepatic Impairment

Hepatic Impairment

United States
Melinta Therapeutics, Inc.

Completed

Pharmacokinetics of Delafloxacin in Subjects With and Without Hepatic Impairment

Hepatic Impairment

United States
Biogen

Completed

BG9928 in Subjects With Hepatic Impairment

Hepatic Impairment

United States
Hutchmed

Completed

Fruquintinib Hepatic Impairment Study

Hepatic Impairment

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Tepotinib Hepatic Impairment Trial

Hepatic Impairment

United States
Eisai Inc.
Purdue Pharma LP

Completed

Study to Evaluate the Pharmacokinetics of Lemborexant (E2006) and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared to Healthy Subjects

Hepatic Impairment

United States
Pfizer

Completed

A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Hepatic Impairment

United States
Intercept Pharmaceuticals

Completed

Hepatic Impairment Trial of Obeticholic Acid

Hepatic Impairment

United States
Zxerex Corporation

Completed

Non-intrusive Detection of Temporary Neurologic Impairment by Opioids

Neurologic Impairment by Opioids

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215

Healthy | Hepatic Impairment

United States
Institut de Recherches Internationales Servier

Completed

A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function

Hepatic Impairment

United States
Pfizer

Completed

Single-Dose PK and Safety Study of GBT440 in Subjects With Hepatic Impairment

Hepatic Impairment

United States
Allergan

Completed

Impact of Severe Hepatic Impairment on Pharmacokinetics of Cenicriviroc and Its Metabolites

Hepatic Impairment

United States
PTC Therapeutics

Completed

A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics

Hepatic Impairment

United States
ApoPharma

Completed

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild and Moderate Hepatic Insufficiency and Healthy Volunteers

Hepatic Impairment

United States
AVEO Pharmaceuticals, Inc.

Completed

A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function

Hepatic Impairment

United States
VIVUS LLC
Covance; Sentrx

Completed

A Study to Evaluate the Pharmacokinetics of VI-0521 in Subjects With Hepatic Impairment

Hepatic Impairment

United States
University of California, San Francisco
National Institute on Aging (NIA)

Completed

Impact of Musical Improvisation Training on Cognitive Function in Older Adults

Cognitive Impairment | Aging | Mild Cognitive Impairment | Cognitive Training | Cognitive Aging | Cognitively Normal Older Adults

United States
Lykos Therapeutics

Not yet recruiting

MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function

Pharmacokinetics | Hepatic Impairment

United States
Exelixis

Completed

Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects

Healthy | Hepatic Impairment

United States
University of Alabama at Birmingham
University of California, Riverside

Recruiting

Scotoma Perimetry Oculomotor Training (SPOT)

Macular Degeneration | Central Visual Impairment

United States
Rush University Medical Center

Active, not recruiting

Lifestyle Physical Activity and Cognitive Training Interventions (MindMoves)

Cardiovascular Diseases | Cognitive Impairment | Cognitive Dysfunction | Mild Cognitive Impairment | Cognitive Decline

United States
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Brain Aging and Treatment Response in Geriatric Depression

Depression | Mild Cognitive Impairment (MCI)

United States
Georgia Institute of Technology
National Institute on Aging (NIA)

Recruiting

Neurobiological Mechanisms of Aging and Stress on Prospective Navigation

Anxiety | Aging | Memory Impairment

United States
Arizona State University
Mayo Clinic; University of Minnesota; University of Rochester; University of St...

Recruiting

The ACT Trial: Effects of Combined Aerobic Exercise and Cognitive Training in MCI

Mild Cognitive Impairment

United States
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.

Completed

Effect of Mild Hepatic Impairment on the Pharmacokinetics of Istradefylline

Hepatic Impairment

United States
Hutchison Medipharma Limited

Completed

Surufatinib Hepatic Impairment Study

Hepatic Impairment

United States
F2G Biotech GmbH

Completed

A Phase I Study to Assess the Pharmacokinetics of Olorofim in Subjects With Hepatic Impairment

Hepatic Impairment

United States
Vanderbilt University Medical Center

Completed

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Breast Cancer | Chemotherapy-related Cognitive Impairment | Chemo Fog | Chemo Brain | Chemobrain

United States
Albert Einstein College of Medicine
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

5-Cog Battery for Detecting Cognitive Impairment and Dementia (5-Cog)

Neurocognitive Disorders | Cognitive Impairment | Dementia | Mild Cognitive Impairment

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics Study of FIA586 in Participants With Mild and Moderate Hepatic Impairment

Hepatic Impairment

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics of Fevipiprant (QAW039) in Patients With Hepatic Impairment Compared to Matched Healthy Subjects

Hepatic Impairment

United States
University of Alabama at Birmingham
University of California, Riverside

Recruiting

Factors in Learning And Plasticity: Macular Degeneration (FLAP)

Macular Degeneration | Central Visual Impairment

United States
Johns Hopkins University
National Institute on Deafness and Other Communication Disorders (NIDCD)

Recruiting

K-HEARS MCI: Hearing Health Care for Korean American Older Adults With Mild Cognitive Impairment (K-HEARS MCI)

Mild Cognitive Impairment | Personal Communication | Age-related Hearing Impairment

United States
Concert Pharmaceuticals

Completed

Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543

Hepatic Impairment

United States
Agios Pharmaceuticals, Inc.

Completed

A Study of AG-120 (Ivosidenib) in Subjects With Mild or Moderate Hepatic Impairment or Normal Hepatic Function

Hepatic Impairment

United States
Trius Therapeutics LLC

Completed

A PK and Safety Study in Subjects With Hepatic Impairment

Hepatic Impairment

United States
FUJIFILM Toyama Chemical Co., Ltd.
Celerion

Completed

PK Study of T-817 in Subjects With Hepatic Impairment

Healthy | Hepatic Impairment

United States
MDVI, LLC

Completed

Pharmacokinetics of Favipiravir in Volunteers With Hepatic Impairment

Healthy | Hepatic Impairment

United States
Nova Southeastern University

Completed

Low Vision Patients' Preference for Colored Filters and Illumination for Near Reading Determined by the LuxIQ/2

Ocular Conditions Resulting in Visual Impairment

United States
Shire

Completed

Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function

Healthy | Hepatic Impairment

United States
VA Office of Research and Development

Completed

Evaluating the CG ASSIST Program for Caregiving Dyads (CG ASSIST)

Transfer Impairment

United States

Clinical Trials on Thermoregulation Impairment in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations